First‐line nab ‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer: Results of the NEPTUN study-Reference-Cited by-同舟云学术

First‐line nab ‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer: Results of the NEPTUN study

Published:2021-10-20 Issue:22 Volume:10 Page:8127-8137
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Dechow Tobias¹^ORCID,Riera‐Knorrenschild Jorge²,Hackanson Björn³,Janssen Jan⁴,Schulz Holger⁵,Chiabudini Marco⁶,Fischer von Weikersthal Ludwig⁷,Budweiser Stephan⁸,Nacke Axel⁹,Taeuscher Dagmar¹⁰,Welslau Manfred¹¹,Potthoff Karin¹²

Affiliation:

1. Practice for Oncology Ravensburg Ravensburg Germany

2. University Hospital Giessen and Marburg GmbH Marburg Germany

3. University Medical Center Augsburg Augsburg Germany

4. Practice for Hematology and Oncology Westerstede Germany

5. Practice for Internal Oncology and Hematology Frechen Germany

6. Department of Biostatistics iOMEDICO Freiburg Germany

7. Health Center St. Marien GmbH Amberg Germany

8. Hospital Rosenheim Rosenheim Germany

9. Practice for Hematology and Oncology Remagen Germany

10. SRH Wald‐Klinikum Gera GmbH Gera Germany

11. Medical Care Center at Hospital Aschaffenburg GmbH Aschaffenburg Germany

12. Medical Department iOMEDICO Freiburg Germany

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4310

Reference26 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Lung Cancer Statistics

3. EttingerDS WoodDE AisnerDLet al. National Comprehensive Cancer Network NCCN. clinical practice guidelines in oncology (NCCN Guidelines) non‐small cell lung cancer. Version 2.2021.

4. Lung cancer: current therapies and new targeted treatments

5. Testing for and frequency of molecular alterations in patients with advanced NSCLC in Germany. Results from the prospective German registry CRISP (AIO-TRK-0315)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and laboratory parameters in patients across metastatic tumor sites;International Journal of Molecular and Immuno Oncology;2024-07-24